Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin inhalation in non-cystic fibrosis bronchiectasis
2009-009869-34Phase 2Completed
- Sponsor
- Bayer
- Start
- Mar 2009
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bronchiectasis comparing Ciprofloxacin inhale with Placebo (2 arms). Primary endpoint: Change from baseline in total bacterial load in sputum. Started Mar 2009; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on 2009-009869-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009869-34.